Infusio Announces EVO Takeover of Management and Facilities
EVO will be taking over Infusio facilities and management as of February 1st, 2020.
FRANKFURT, Germany, Jan. 24, 2020 /PRNewswire-PRWeb/ -- EVO, a renowned health & wellness institute has acquired the INFUSIO® franchise with locations in Beverly Hills, California, and Frankfurt, Germany. The launch will take place February 1st 2020 and marks the end of the Infusio treatment concept which was established in Germany in 2011 and opened its first treatment center in the U.S. in 2014.
EVO stands for evolve – vitalize – optimize. Its menu of services will focus on diabetes care, burnout management, exosome therapy as well as offer support for patients with cancer, CFS/ME, Lyme Disease, Lupus and auto immune disease. Also, EVO is introducing the latest research in cell-based treatments for traumatic brain injury caused by concussion, stroke and repeated micro-trauma.
In the US, EVO's sports medicine treatments will cater to active individuals & athletes with its stem-cell based treatments for joint injuries and back pain. In addition, the EVO Beverly Hills facility will offer Emsculpt®, SaltFacial®, aesthetic treatments and customized skincare.
The EVO Frankfurt treatment center is proud to become one of the few clinics in Europe to offer a revolutionary new treatment for cancer patients. In collaboration with a state-of-the-art laboratory, personalized cancer vaccines are used to apply highly individualized immunotherapies and offer hope and treatment alternatives to cancer patients. The therapy combines dendritic cells with peptides, which are individually crafted by sequencing material from the patient's tumor and microparticles in the blood. This new technology marks a new era in individualized cancer treatment and is considered the future of personalized immunotherapy. This method is not only applicable for the supportive treatment of cancer but can also be adapted for the treatment of autoimmune disease, ME/CFS and Lyme disease.
Another unique therapy EVO will be offering is pulsatile intravenous insulin therapy known as PIVIT. This treatment is currently being pioneered in the US as an option for patients with Diabetes Type 1 and Type 2 as well as a solution for many of the associated diabetic complications such as neuropathy, nephropathy and erectile disfunction. Initial studies show that 93% of patients with neuropathy are showing significant improvement or complete remission. As this treatment focusses on metabolic restoration it can be applied to patients with metabolic syndrome and chronic inflammatory disease.
EVO will be offering a new format of wellness and holistic healthcare, transforming the old infrastructure and protocols while also implementing new team members with the expertise in patient care, science & medicine. Jonathan Kohanim, Director of Operations, says what clients can expect: "We are excited to offer cutting-edge treatments on two continents creating a state-of-the-art health & wellness retreat that offers clients everything to achieve optimal health and have you look and feel your best."
Dr. Amin Javid, EVO's musculoskeletal specialist says: "EVO is the perfect fusion of wellness and science. Our patients come here because everything is offered under one roof right in the heart of Beverly Hills. For me, this is the future of healthcare"
More details on EVO's treatments and services are to be released within the following weeks on EVO's websites.
Contact EVO for more information on available treatments:
EVO Beverly Hills
(800) 470-6229
[email protected].
EVO Frankfurt
+49 69 207 34 940
[email protected]
To learn more about EVO's personalized and innovative healthcare approach visit http://www.evobeverlyhills.com or http://www.evofrankfurt.com.
SOURCE EVO Frankfurt
Share this article